NASDAQ:MTSR Metsera (MTSR) Stock Price, News & Analysis $40.59 +0.93 (+2.34%) As of 01:15 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About Metsera Stock (NASDAQ:MTSR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Metsera alerts:Sign Up Key Stats Today's Range$37.29▼$40.5950-Day Range$25.38▼$44.3052-Week Range$12.30▼$47.40Volume481,368 shsAverage Volume898,198 shsMarket Capitalization$4.26 billionP/E RatioN/ADividend YieldN/APrice Target$55.00Consensus RatingBuy Company Overview Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o. The company was founded by Clive A. Meanwell in 2022 and is headquartered in New York. Read More Receive MTSR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Metsera and its competitors with MarketBeat's FREE daily newsletter. Email Address MTSR Stock News HeadlinesMetsera Inc.'s (NASDAQ:MTSR) Lock-Up Period To Expire on July 30thJuly 25 at 3:29 AM | americanbankingnews.comMetsera (NASDAQ:MTSR) Reaches New 52-Week High - Should You Buy?July 20, 2025 | americanbankingnews.comYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.July 25 at 2:00 AM | Priority Gold (Ad)Metsera (MTSR) Presented at the 85th Scientific Sessions of the American Diabetes AssociationJuly 14, 2025 | finance.yahoo.comMetsera Clears Key Benchmark, Hitting 90-Plus RS RatingJuly 9, 2025 | msn.comWall Street Analysts See an 89.66% Upside in Metsera Inc. (MTSR): Can the Stock Really Move This High? - NasdaqJune 26, 2025 | nasdaq.comWells Fargo Initiates Coverage of Metsera (MTSR) with Overweight RecommendationJune 20, 2025 | msn.comPromising Results Of Amylin Analogs In Obesity: Metsera Case ReviewJune 12, 2025 | seekingalpha.comSee More Headlines MTSR Stock Analysis - Frequently Asked Questions How have MTSR shares performed this year? Metsera's stock was trading at $29.50 at the start of the year. Since then, MTSR stock has increased by 28.4% and is now trading at $37.89. How were Metsera's earnings last quarter? Metsera Inc. (NASDAQ:MTSR) issued its quarterly earnings results on Monday, May, 12th. The company reported ($1.03) EPS for the quarter. When did Metsera IPO? Metsera (MTSR) raised $275 million in an initial public offering (IPO) on Friday, January 31st 2025. The company issued 15,277,778 shares at $18.00 per share. When does the company's lock-up period expire? Metsera's lock-up period expires on Wednesday, July 30th. Metsera had issued 15,277,778 shares in its initial public offering on January 31st. The total size of the offering was $275,000,004 based on an initial share price of $18.00. After the end of the company's lock-up period, major shareholders and company insiders will be able to sell their shares of the company. Who are Metsera's major shareholders? Metsera's top institutional investors include Exchange Traded Concepts LLC (0.04%) and KLP Kapitalforvaltning AS. How do I buy shares of Metsera? Shares of MTSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/12/2025Today7/25/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:MTSR Previous SymbolNASDAQ:MTSR CIK2040807 WebN/A Phone(212) 784-6595FaxN/AEmployees81Year FoundedN/APrice Target and Rating Average Price Target for Metsera$55.00 High Price Target$65.00 Low Price Target$38.00 Potential Upside/Downside+38.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio6.55 Quick Ratio6.55 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($2.46) per share Price / Book-16.12Miscellaneous Outstanding Shares105,060,000Free FloatN/AMarket Cap$4.17 billion OptionableN/A BetaN/A Social Links These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:MTSR) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredThe big winner of Crypto week?It’s Crypto Week at the White House — and the sector is moving from fringe to full-scale adoption. With Bit...Weiss Ratings | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metsera Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Metsera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.